![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 38, 35405-35413, September 21, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, and
From the Centro de Investigación del Cáncer, Instituto
de Biología Molecular y Celular del Cáncer, Consejo
Superior de Investigaciones Científicas, Universidad de
Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain and the
Unidad de Genética y Medicina Molecular, Centro Nacional de
Biología Fundamental, Instituto de Salud Carlos III,
E-28220 Majadahonda, Spain
CD53 is a tetraspanin protein mostly expressed in
to the lymphoid-myeloid lineage. We have characterized the human
CD53 gene regulatory region. Within the proximal 2 kilobases, and with opposite transcriptional orientation, is located
the promoter-enhancer of a second gene, which does not affect
CD53. Twenty-four copies of a CA dinucleotide repeat
separate these two gene promoters. The proximal enhanceosome of the
human CD53 gene is comprised between residues
266 and
+84, and can be subdivided into four major subregions, two of them
within exon 1. Mutational analysis identified several cooperating
sequences. An Sp1 and an ets-1 site, at positions
115 and +62,
respectively, are essential for transcriptional competence in all cell
lines. Five other regulatory sequences have a dual role, activator or
down-regulator, depending on the cell line. At the end of the
non-coding exon 1, +64 to +83, there is a second ets-1 regulatory
element, which is required for high level of transcription, in
cooperation with the Sp1 site, in K562 and Molt-4, but not in Namalwa
cells, where it functions as a repressor. This Sp1 site also cooperates
with another ets-1/PU.1 site at
172. Different cell types use
different regulatory sequences in the enhanceosome for the expression
of the same gene.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ243474.
Supported by a fellowship from the Instituto de Salud Carlos III.
§
To whom correspondence should be addressed: Centro de
Investigación del Cáncer, CSIC-Universidad de Salamanca,
Campus Miguel de Unamuno, E-37007 Salamanca, Spain. Tel.:
34-923-294-804; Fax: 34-923-294-795; E-mail: plazozbi@usal.es.
This article has been cited by other articles:
![]() |
M. R. Bonello, Y. V. Bobryshev, and L. M. Khachigian Peroxide-Inducible Ets-1 Mediates Platelet-Derived Growth Factor Receptor-{alpha} Gene Transcription in Vascular Smooth Muscle Cells Am. J. Pathol., October 1, 2005; 167(4): 1149 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Valor, M. Castillo, J. A. Ortiz, and M. Criado Transcriptional Regulation by Activation and Repression Elements Located at the 5'-Noncoding Region of the Human {alpha}9 Nicotinic Receptor Subunit Gene J. Biol. Chem., September 26, 2003; 278(39): 37249 - 37255. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Henkel, S. R. McKercher, and R. A. Maki Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells Int. Immunol., July 1, 2002; 14(7): 723 - 732. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |